NCT02497391View on ClinicalTrials.gov

A Study of Different Particle Sizes of Evacetrapib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Healthy
Interventions
DRUG

Evacetrapib

administered orally

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02497391 - A Study of Different Particle Sizes of Evacetrapib in Healthy Participants | Biotech Hunter | Biotech Hunter